Blog
RUNIT: A historical perspective from Stephen Casper, PhD
People who take part in these sports might think they are in control of the risks, but brain injuries can happen fast and change a person’s life forever. These injuries can cause immediate death or lead to lifelong disabilities that affect every part of a person’s life. Many people who get hurt by perfect brain injury delivery systems say they had no idea how bad it could be until it was too late.
Leading experts propose a new framework for diagnosing traumatic brain injury
In a significant paradigm shift, 50 years in the making, 94 experts from 14 countries have proposed a new, multidimensional framework for classifying traumatic brain injury (TBI).
Co-occurrence of depression and concussion worsens symptoms in collegiate athletes
A study highlights that the co-occurrence of concussion and depression is “associated with significantly worse symptoms for both conditions.” Despite overlapping symptoms, these conditions are often treated independently, overlooking their additive effects.
Meditation techniques associated with lower cortisol levels for at-risk populations
A recent study suggests that different meditation interventions (particularly those focused on mindfulness) benefit individuals at risk for high cortisol levels––especially for those with a somatic (physical) illness.
Download a free, high-quality mindfulness app
Learn about a free, high-quality mindfulness app created by UCLA Mindfulness Education Center ; our previous newsletter covered meditation, particularly mindfulness, for at-risk populations.
Neuroscientist breaks down misconceptions about concussions
Neuroscientist Richard Sima has written a terrific article for the Washington Post explaining what concussions are–and the serious nature of these mild traumatic brain injuries (mTBI).
Clinical trial for a CBD pill for concussions
The first US-based clinical trial on CBD treatment for concussion is being conducted by the University of Miami. The five-year, three-stage study is funded by a $16 million grant from Canadian company Scythian Biosciences. The clinical trial will conduct research on a pill that combines CBD and dexanabiol, which researchers believe will reduce brain inflammation. See also the Miami Herald article.